Influence of cirrhosis on outcomes of patients with advanced intrahepatic cholangiocarcinoma receiving chemotherapy-Reference-Cited by-同舟云学术

Influence of cirrhosis on outcomes of patients with advanced intrahepatic cholangiocarcinoma receiving chemotherapy

Published:2023-10-09 Issue:11 Volume:129 Page:1766-1772
ISSN:0007-0920
Container-title:British Journal of Cancer
language:en
Short-container-title:Br J Cancer

Author:

d’Abrigeon Constance,McNamara Mairéad G.^ORCID,Le Sourd Samuel,Lamarca Angela,Lièvre Astrid^ORCID,Bourien Héloïse,Peinoit Alexandre,Uguen Thomas,Hubner Richard A.,Valle Juan W.^ORCID,Edeline Julien^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

https://www.nature.com/articles/s41416-023-02460-2.pdf

Reference15 articles.

1. Chang KY, Chang JY, Yen Y. Increasing incidence of intrahepatic cholangiocarcinoma and its relationship to chronic viral hepatitis. J Natl Compr Cancer Netw JNCCN. 2009;7:423–7.

2. Lamarca A, Benafif S, Ross P, Bridgewater J, Valle JW. Cisplatin and gemcitabine in patients with advanced biliary tract cancer (ABC) and persistent jaundice despite optimal stenting: effective intervention in patients with luminal disease. Eur J Cancer. 2015;51:1694–703.

3. Izquierdo-Sanchez L, Lamarca A, La Casta A, Buettner S, Utpatel K, Klümpen HJ, et al. Cholangiocarcinoma landscape in Europe: diagnostic, prognostic and therapeutic insights from the ENSCCA Registry. J Hepatol. 2022;76:1109–21.

4. Alison MR, Lovell MJ. Liver cancer: the role of stem cells. Cell Prolif. 2005;38:407–21.

5. Roskams T. Liver stem cells and their implication in hepatocellular and cholangiocarcinoma. Oncogene. 2006;25:3818–22.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pembrolizumab en association à une chimiothérapie par gemcitabine–cisplatine en première ligne des cancers des voies biliaires avancés;Bulletin du Cancer;2024-06

2. Perioperative and palliative systemic treatments for biliary tract cancer;Therapeutic Advances in Medical Oncology;2024-01